Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 7,934,000 | 7,739,000 | 6,995,000 | 6,944,000 | 6,538,000 |
| Cost of Goods | 1,927,000 | 2,281,000 | 1,616,000 | 1,529,000 | 1,616,000 |
| Gross Profit | 6,007,000 | 5,458,000 | 5,379,000 | 5,415,000 | 4,922,000 |
| Operating Expenses | 3,104,000 | 3,676,000 | 2,685,000 | 2,753,000 | 2,515,000 |
| Operating Income | 2,903,000 | 1,782,000 | 2,694,000 | 2,662,000 | 2,407,000 |
| Interest Expense | 251,000 | 252,000 | 252,000 | 253,000 | 247,000 |
| Other Income | 145,000 | -337,000 | -347,000 | -56,000 | -74,000 |
| Pre-tax Income | 2,797,000 | 1,193,000 | 2,095,000 | 2,353,000 | 2,086,000 |
| Income Tax | 14,000 | 1,141,000 | 464,000 | 438,000 | 375,000 |
| Net Income Continuous | 2,783,000 | 52,000 | 1,631,000 | 1,915,000 | 1,711,000 |
| Net Income | $2,783,000 | $52,000 | $1,631,000 | $1,915,000 | $1,711,000 |
| EPS Basic Total Ops | 1.74 | 0.02 | 1.02 | 1.20 | 1.07 |
| EPS Basic Continuous Ops | 1.75 | 0.03 | 1.02 | 1.20 | 1.07 |
| EPS Diluted Total Ops | 1.74 | 0.04 | 1.01 | 1.19 | 1.06 |
| EPS Diluted Continuous Ops | 1.74 | 0.03 | 1.02 | 1.20 | 1.07 |
| EBITDA(a) | $3,348,000 | $2,151,000 | $3,073,000 | $3,041,000 | $2,781,000 |